株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

自己免疫性肝炎 (AIH) 診断・治療の世界市場:分析・予測

Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 785696
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
自己免疫性肝炎 (AIH) 診断・治療の世界市場:分析・予測 Global Autoimmune Hepatitis Diagnosis and Treatment Market Forecast, 2018-2023
出版日: 2019年01月18日 ページ情報: 英文
概要

当レポートでは、世界の自己免疫性肝炎 (AIH) 診断・治療市場について調査分析し、市場概要、市場決定要因、市場区分、競合情勢、地域別分析、主要企業などについて、体系的な情報を提供しています。

第1章 調査サマリー

第2章 市場概要と考察

  • 定義
  • アナリストの考察・現在の市場動向
  • 規制

第3章 市場決定要因

  • 促進要因
  • 抑制要因
  • 機会

第4章 市場区分

  • 世界の自己免疫性肝炎 (AIH) 診断・治療市場:診断方法別
    • 血液検査
    • 画像検査
    • 肝生検
  • 世界の自己免疫性肝炎 (AIH) 診断・治療市場:治療方法別
    • 薬物
    • 肝臓移植
  • 世界の自己免疫性肝炎 (AIH) 診断・治療市場:タイプ別別
    • タイプI
    • タイプII
    • バリアントAIH

第5章 競合情勢

  • 主要企業分析
  • 主要戦略

第6章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋地域
    • インド
    • 中国
    • 日本
    • その他のアジア太平洋
  • その他 (RoW)

第7章 企業プロファイル

  • Abbott Laboratories, Inc.
  • AbbVie, Inc.
  • Arihantanam Life Care Pvt Ltd.
  • AstraZeneca PLC
  • Bayer AG
  • Biocon, Ltd.
  • Bio-Rad Laboratories, Inc.
  • Bristol-Myers Squibb Co.
  • Cipla, Ltd.
  • GlaxoSmithKline PLC
  • Gilead Lifesciences, Inc.
  • Johnson & Johnson Services, Inc.
  • Inova Diagnostics, Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Organovo Holdings, Inc.
  • Pfizer, Inc.
  • Principia Biopharma, Inc.
  • Revive Therapeutics, Ltd.
  • Upcyte Technologies GmbH
図表

List of Tables

  • TABLE # 1 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
  • TABLE # 2 GLOBAL BLOOD TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 3 GLOBAL IMAGING TEST MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 4 GLOBAL LIVER BIOPSY MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 5 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
  • TABLE # 6 GLOBAL MEDICATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 7 GLOBAL LIVER TRANSPLANT MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 8 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 9 GLOBAL TYPE-I MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 10 GLOBAL TYPE-II MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 11 GLOBAL VARIANT MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 12 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 13 GLOBAL HOSPITALS AND CLINIC MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 14 GLOBAL DIAGNOSTIC CENTRE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 15 GLOBAL RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023 ($ MILLION)
  • TABLE # 16 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2017-2023 ($ MILLION)
  • TABLE # 17 NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 18 NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
  • TABLE # 19 NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
  • TABLE # 20 NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 21 NORTH AMERICAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 22 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 23 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
  • TABLE # 24 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
  • TABLE # 25 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 26 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 27 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023 ($ MILLION)
  • TABLE # 28 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
  • TABLE # 29 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
  • TABLE # 30 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 31 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)
  • TABLE # 32 REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2017-2023 ($ MILLION)
  • TABLE # 33 REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2017-2023 ($ MILLION)
  • TABLE # 34 REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2017-2023 ($ MILLION)
  • TABLE # 35 REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023 ($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY DIAGNOSIS, 2017 VS 2023 (%)
  • FIGURE # 2 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY TREATMENT, 2017 VS 2023 (%)
  • FIGURE # 3 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY TYPE, 2017 VS 2023 (%)
  • FIGURE # 4 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY END-USER, 2017 VS 2023 (%)
  • FIGURE # 5 GLOBAL AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SHARE BY GEOGRAPHY, 2017 VS 2023 (%)
  • FIGURE # 6 NORTH AMERICA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 7 US AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 8 CANADA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 9 EUROPEAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 10 UK AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 11 FRANCE AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 12 GERMANY AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 13 ITALY AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 14 SPAIN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 15 ROE AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 16 ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 17 INDIA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 18 CHINA AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 19 JAPAN AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 20 REST OF ASIA-PACIFIC AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
  • FIGURE # 21 REST OF THE WORLD AUTOIMMUNE HEPATITIS DIAGNOSIS AND TREATMENT MARKET SIZE, 2017-2023 ($ MILLION)
目次
Product Code: OMR2019499

Autoimmune hepatitis (AIH) is a chronic and long-lasting disease which are caused due to the immune system of the body which attacks the normal cells of the body and lead to liver damage and cirrhosis. The disease occurs due to the inherited tendency or genetic predisposition which can grow the demand for autoimmune hepatitis medication. There are mainly two types of autoimmune hepatitis which include type-I, type-II and Variant AIH. Autoimmune hepatitis can be diagnosed with different diagnosis procedure such as blood test, an imaging test, and liver biopsy. The autoimmune hepatitis treatment can be done either by medication such as corticosteroids and other immune system suppressors medicines or by a liver transplant. Presence of a wider range of product is the major driving factor for autoimmune hepatitis market. Moreover, the change in lifestyle and consumption of alcohol is leading to severe liver diseases and creating the demand for autoimmune hepatitis diagnosis and treatment across the globe.

Although, the stringent regulation for liver transplantation is the major restraining factor for the growth of the autoimmune hepatitis diagnosis and treatment market. In addition, the treatment cost is very high, and the liver transplant can cause the risk of trauma to the remaining kidney which is hindering the adoption of liver translation, thus constraining the growth of the market. Whereas, the increasing healthcare expenditure and the development of healthcare infrastructure in emerging countries will turn out to be a huge opportunity for this market. Further, the presence of strong pipeline product will also create enormous opportunities for the market in near future.

Geographically market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is dominating the overall global autoimmune hepatitis diagnosis and treatment market. The factors that are driving the growth of the market are high consumption of alcohol and the developed infrastructure. Further, the presence of a strong market player within the region is also a major factor for its dominance. Additionally, Europe is the second largest market due to the increasing healthcare expenditure in order to provide a better quality of life. Along with it, rising awareness of organ transplant treatment and the government initiative are the major driving factor for autoimmune hepatitis market in Asia-Pacific region.

There is a large number of market players contributing in the global hepatitis diagnosis and treatment market includes Abbott Laboratories, Inc., Novartis International AG, Gilead Lifesciences, Inc., MercK & Co., Inc., Bio-Rad laboratories, Inc. and so on. These companies are continuously making efforts to stay competitive in the market. These companies are adopting various strategies such as merger & acquisition, partnership & collaboration, product launch, and geographical expansion.

Research methodology

The market study of autoimmune hepatitis diagnosis and treatment market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic public databases such as the FDA, OECD, WHO, and others
  • Whitepapers, research-papers and news blogs
  • Company websites and their product catalog.

The report is intended for the pharmaceutical drug manufacturer, investing companies, Government Organizations for overall market analysis and competitive analysis. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market segmentation

Global autoimmune hepatitis diagnosis and treatment market are segmented on the basis of regional outlook and following segments:

  • 1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis
  • 2. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment
  • 3. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type
  • 4. Global Autoimmune Hepatitis Diagnosis and Treatment Market by End-User

The report covers:

  • Comprehensive research methodology of the global autoimmune hepatitis diagnosis and treatment
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global autoimmune hepatitis diagnosis and treatment market.
  • Insights about market determinants which are stimulating the global autoimmune hepatitis diagnosis and treatment
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders
    • 1.2.4. Exceptions

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Regulation

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Increasing Side Effects Associated Prescribed Medications and Infections
    • 3.1.2. Increasing Prevalence of Autoimmune Hepatitis
    • 3.1.3. Change in Lifestyle and High Alcohol Consumption Rate in Emerging Countries
    • 3.1.4. Widespread Product Portfolio Offered by Key Market Players
  • 3.2. Restraints
    • 3.2.1. High Cost of Medication
    • 3.2.2. Stringent Regulations Related to Liver Transplant
  • 3.3. Opportunities
    • 3.3.1. Development of Healthcare Infrastructure
    • 3.3.2. Strong Product Pipeline
    • 3.3.3. Government Support for Rising Awareness

4. Market Segmentation

  • 4.1. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Diagnosis
    • 4.1.1. Blood Test
    • 4.1.2. Imaging Test
    • 4.1.3. Liver Biopsy
  • 4.2. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Treatment
    • 4.2.1. Medication
      • 4.2.1.1. Corticosteroids (Cortisone, Hydrocortisone and Prednisone)
      • 4.2.1.2. Immune System Suppressors
    • 4.2.2. Liver Transplant
  • 4.3. Global Autoimmune Hepatitis Diagnosis and Treatment Market by Type
    • 4.3.1. Type-I
    • 4.3.2. Type-II
    • 4.3.3. Variant AIH
  • 4.4. Global Autoimmune Hepatitis Diagnosis and Treatment Market by End-User
    • 4.4.1. Hospitals and Clinics
    • 4.4.2. Diagnostic Centre
    • 4.4.3. Research Institutions

5. Competitive Landscape

  • 5.1. Key Company Analysis
  • 5.2. Key Strategies

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Spain
    • 6.2.4. France
    • 6.2.5. Italy
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories, Inc.
  • 7.2. AbbVie, Inc.
  • 7.3. Arihantanam Life Care Pvt Ltd.
  • 7.4. AstraZeneca PLC
  • 7.5. Bayer AG
  • 7.6. Biocon, Ltd.
  • 7.7. Bio-Rad Laboratories, Inc.
  • 7.8. Bristol-Myers Squibb Co.
  • 7.9. Cipla, Ltd.
  • 7.10. GlaxoSmithKline PLC
  • 7.11. Gilead Lifesciences, Inc.
  • 7.12. Johnson & Johnson Services, Inc.
  • 7.13. Inova Diagnostics, Inc.
  • 7.14. Merck & Co., Inc.
  • 7.15. Novartis International AG
  • 7.16. Organovo Holdings, Inc.
  • 7.17. Pfizer, Inc.
  • 7.18. Principia Biopharma, Inc.
  • 7.19. Revive Therapeutics, Ltd.
  • 7.20. Upcyte Technologies GmbH
Back to Top